Nomura Asset Management CO LTD Biocryst Pharmaceuticals Inc Transaction History

Nomura Asset Management CO LTD

10 transactions

Quarter	Operation	Price Per share
Q3 2023 Nov 03, 2023	BUY	$6.71 - $7.92 $0 - $0
Q2 2023 Aug 14, 2023	BUY	$6.96 - $8.81 $0 - $0
Q1 2023 May 11, 2023	BUY	$7.94 - $11.84 $0 - $0
Q4 2022 Feb 14, 2023	BUY	$10.5 - $14.2 $0 - $0
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $0 - $0
Q3 2022 Nov 10, 2022	BUY	$10.79 - $14.81 $0 - $0
Q3 2022 Nov 10, 2022	BUY	$10.79 - $14.81 $0 - $0
Q2 2022 Aug 12, 2022	BUY	$7.89 - $17.88 $0 - $0
Q1 2022 May 13, 2022	BUY	$11.56 - $19.76 $0 - $0
Q4 2021 Feb 01, 2022	BUY	$11.18 - $15.46 $0 - $0

280

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.39B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.